These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9210979)

  • 21. Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model.
    Ekstrøm PO; Anderson A; Warren DJ; Giercksky KE; Slørdal L
    Cancer Chemother Pharmacol; 1995; 36(4):283-9. PubMed ID: 7628046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of C6 and CNS1 brain tumors on methotrexate pharmacokinetics in plasma and brain tissue.
    Dukic SF; Kaltenbach ML; Heurtaux T; Hoizey G; Lallemand A; Vistelle R
    J Neurooncol; 2004; 67(1-2):131-8. PubMed ID: 15072460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of methotrexate after intravenous and intramuscular injection of methotrexate-bearing positively charged liposomes to rats.
    Kim MM; Lee SH; Lee MG; Hwang SJ; Kim CK
    Biopharm Drug Dispos; 1995 May; 16(4):279-93. PubMed ID: 7548777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synovial and serum levels of methotrexate during methotrexate therapy of rheumatoid arthritis.
    Tishler M; Caspi D; Graff E; Segal R; Peretz H; Yaron M
    Br J Rheumatol; 1989 Oct; 28(5):422-3. PubMed ID: 2790404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced transdermal absorption of N,N-diethyl-m-toluamide from a new topical insect repellent formulation.
    Qiu H; Jun HW; Dzimianski M; McCall J
    Pharm Dev Technol; 1997 Feb; 2(1):33-42. PubMed ID: 9552429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue disposition of the insect repellent DEET and the sunscreen oxybenzone following intravenous and topical administration in rats.
    Fediuk DJ; Wang T; Chen Y; Parkinson FE; Namaka MP; Simons KJ; Burczynski FJ; Gu X
    Biopharm Drug Dispos; 2011 Oct; 32(7):369-79. PubMed ID: 21812003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.
    Joerger M; Huitema AD; van den Bongard HJ; Baas P; Schornagel JH; Schellens JH; Beijnen JH
    Br J Clin Pharmacol; 2006 Jul; 62(1):71-80. PubMed ID: 16842380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J; Hak J; Martínková J; Chládek J
    Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous characterization of the insect repellent DEET and the sunscreen oxybenzone from topical skin application.
    Kasichayanula S; House JD; Wang T; Gu X
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):187-94. PubMed ID: 17602720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint.
    Liang LS; Jackson J; Min W; Risovic V; Wasan KM; Burt HM
    J Pharm Sci; 2004 Apr; 93(4):943-56. PubMed ID: 14999731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.
    Innocenti F; Danesi R; Di Paolo A; Loru B; Favre C; Nardi M; Bocci G; Nardini D; Macchia P; Del Tacca M
    Cancer Chemother Pharmacol; 1996; 37(5):409-14. PubMed ID: 8599862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia.
    Kinoshita A; Kurosawa Y; Kondoh K; Suzuki T; Manabe A; Inukai T; Sugita K; Nakazawa S
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):256-60. PubMed ID: 12655445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on in vitro and in vivo transdermal flux enhancement of methotrexate by a combinational approach in comparison to oral delivery.
    Prasad R; Anand S; Khar RK; Dinda AK; Koul V
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1281-92. PubMed ID: 19832628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of extracellular methotrexate tissue levels by microdialysis in a rat model.
    Ekstrøm PO; Andersen A; Warren DJ; Giercksky KE; Slørdal L
    Cancer Chemother Pharmacol; 1996; 37(5):394-400. PubMed ID: 8599860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability of oral bioavailability for low dose methotrexate in rats.
    Kuroda T; Namba K; Torimaru T; Yamamoto S; Akahori M
    Eur J Drug Metab Pharmacokinet; 2001; 26(4):227-34. PubMed ID: 11808864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium Channel Blockers Possibly Delay the Elimination of Plasma Methotrexate in Patients Receiving High-Dose Methotrexate Therapy.
    Inose R; Takahashi K; Nanno S; Hino M; Nagayama K
    J Chemother; 2019 Feb; 31(1):30-34. PubMed ID: 30773130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractional laser-assisted drug delivery: Laser channel depth influences biodistribution and skin deposition of methotrexate.
    Taudorf EH; Lerche CM; Erlendsson AM; Philipsen PA; Hansen SH; Janfelt C; Paasch U; Anderson RR; Haedersdal M
    Lasers Surg Med; 2016 Jul; 48(5):519-29. PubMed ID: 26846733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A spreadsheet-based method for estimating the skin disposition of volatile compounds: application to N,N-diethyl-m-toluamide (DEET).
    Kasting GB; Miller MA; Bhatt VD
    J Occup Environ Hyg; 2008 Oct; 5(10):633-44. PubMed ID: 18668403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in skin permeation of N,N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient.
    Ross1 JS; Shah JC
    J Control Release; 2000 Jul; 67(2-3):211-21. PubMed ID: 10825555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats.
    Dukic S; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Gourdier B; Vistelle R
    Pharm Res; 1999 Aug; 16(8):1219-25. PubMed ID: 10468023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.